Sawtooth Solutions, LLC Editas Medicine, Inc. Transaction History

Sawtooth Solutions, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$39.27 - $72.94 $150,168 - $278,922	-3,824 Closed	0 $0
Q2 2021 Sep 01, 2021	SELL	$31.29 - $56.64 $65,771 - $119,057	-2,102 Reduced 35.47%	3,824 $217,000
Q1 2021 May 13, 2021	BUY	$39.71 - $90.58 $235,321 - $536,777	5,926 New	5,926 $249,000
Q1 2020 May 15, 2020	SELL	$14.88 - $32.78 $118,266 - $260,535	-7,948 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$19.49 - $32.63 $154,906 - $259,343	7,948 New	7,948 $235,000

244

56.8M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Sawtooth Solutions, LLC with notifications on news.